FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127848583> ?p ?o ?g. }

• W2127848583 endingPage "1643" @default.
• W2127848583 startingPage "1639" @default.
• W2127848583 abstract "In RA, response to TNF blockers may be associated with a profile of cytokine production unique to each patient. This study sought to predict the response to biologic agents by examining pro-inflammatory cytokine synthesis in stimulated whole blood cultures (WBCs).We measured the concentration of TNF-α, IL-1β and IL-6 in supernatants of lipopolysaccharide (LPS)-stimulated WBCs obtained from RA patients (n = 41) before anti-TNF therapy (infliximab, 13; etanercept, 26; and adalimumab, 2) and from healthy controls (n = 12). At 24 weeks after biologics, whole bloods were again drawn from 14 of 41 patients. Response was defined by the European League Against Rheumatism response criteria after 24 weeks of therapy.Among 41 patients, 32 were responders (good 14/moderate 18), while 9 were non-responders. All cytokines measured were significantly lower in RA patients than in controls. In RA, IL-1β production was lower in non-responders than in responders [median (interquartile range): 3.5 (1.5-9.4) vs 10.0 (5.1-93.1) pg/ml, P = 0.048]. The area under the curve from a receiver operating characteristic curve analysis for the prediction of response using IL-1β was 0.717 (95% CI 0.520, 0.914). The sensitivity and specificity of IL-1β (cut-off value 4.84 pg/ml) was 78.1 and 77.8%, respectively. All cytokines were significantly higher 6 months later compared with their respective baseline.IL-1β measurement in LPS-stimulated WBC is useful to predict responsiveness to anti-TNF agents. Cytokine production capacities in LPS-stimulated WBCs are up-regulated by biologics." @default.
• W2127848583 created "2016-06-24" @default.
• W2127848583 creator A5001085820 @default.
• W2127848583 creator A5002633417 @default.
• W2127848583 creator A5004957967 @default.
• W2127848583 creator A5009036785 @default.
• W2127848583 creator A5022101230 @default.
• W2127848583 creator A5022382465 @default.
• W2127848583 creator A5029280623 @default.
• W2127848583 creator A5037618766 @default.
• W2127848583 creator A5045767613 @default.
• W2127848583 creator A5051313394 @default.
• W2127848583 date "2012-05-16" @default.
• W2127848583 modified "2023-09-25" @default.
• W2127848583 title "Interleukin-1 measurement in stimulated whole blood cultures is useful to predict response to anti-TNF therapies in rheumatoid arthritis" @default.
• W2127848583 cites W156829367 @default.
• W2127848583 cites W2020663709 @default.
• W2127848583 cites W2023102754 @default.
• W2127848583 cites W2026960752 @default.
• W2127848583 cites W2098279921 @default.
• W2127848583 cites W2101832744 @default.
• W2127848583 cites W2112861894 @default.
• W2127848583 cites W2120063937 @default.
• W2127848583 cites W2122833930 @default.
• W2127848583 cites W2123843419 @default.
• W2127848583 cites W2130631271 @default.
• W2127848583 cites W2134244043 @default.
• W2127848583 cites W2154716537 @default.
• W2127848583 cites W2161130604 @default.
• W2127848583 doi "https://doi.org/10.1093/rheumatology/kes094" @default.
• W2127848583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22596214" @default.
• W2127848583 hasPublicationYear "2012" @default.
• W2127848583 type Work @default.
• W2127848583 sameAs 2127848583 @default.
• W2127848583 citedByCount "31" @default.
• W2127848583 countsByYear W21278485832013 @default.
• W2127848583 countsByYear W21278485832014 @default.
• W2127848583 countsByYear W21278485832015 @default.
• W2127848583 countsByYear W21278485832016 @default.
• W2127848583 countsByYear W21278485832017 @default.
• W2127848583 countsByYear W21278485832018 @default.
• W2127848583 countsByYear W21278485832019 @default.
• W2127848583 countsByYear W21278485832020 @default.
• W2127848583 countsByYear W21278485832021 @default.
• W2127848583 countsByYear W21278485832022 @default.
• W2127848583 crossrefType "journal-article" @default.
• W2127848583 hasAuthorship W2127848583A5001085820 @default.
• W2127848583 hasAuthorship W2127848583A5002633417 @default.
• W2127848583 hasAuthorship W2127848583A5004957967 @default.
• W2127848583 hasAuthorship W2127848583A5009036785 @default.
• W2127848583 hasAuthorship W2127848583A5022101230 @default.
• W2127848583 hasAuthorship W2127848583A5022382465 @default.
• W2127848583 hasAuthorship W2127848583A5029280623 @default.
• W2127848583 hasAuthorship W2127848583A5037618766 @default.
• W2127848583 hasAuthorship W2127848583A5045767613 @default.
• W2127848583 hasAuthorship W2127848583A5051313394 @default.
• W2127848583 hasConcept C119060515 @default.
• W2127848583 hasConcept C126322002 @default.
• W2127848583 hasConcept C1621761 @default.
• W2127848583 hasConcept C17991360 @default.
• W2127848583 hasConcept C198451711 @default.
• W2127848583 hasConcept C203014093 @default.
• W2127848583 hasConcept C2777138892 @default.
• W2127848583 hasConcept C2777226972 @default.
• W2127848583 hasConcept C2777489490 @default.
• W2127848583 hasConcept C2777575956 @default.
• W2127848583 hasConcept C2778690821 @default.
• W2127848583 hasConcept C2780132546 @default.
• W2127848583 hasConcept C71924100 @default.
• W2127848583 hasConcept C76318530 @default.
• W2127848583 hasConcept C90924648 @default.
• W2127848583 hasConceptScore W2127848583C119060515 @default.
• W2127848583 hasConceptScore W2127848583C126322002 @default.
• W2127848583 hasConceptScore W2127848583C1621761 @default.
• W2127848583 hasConceptScore W2127848583C17991360 @default.
• W2127848583 hasConceptScore W2127848583C198451711 @default.
• W2127848583 hasConceptScore W2127848583C203014093 @default.
• W2127848583 hasConceptScore W2127848583C2777138892 @default.
• W2127848583 hasConceptScore W2127848583C2777226972 @default.
• W2127848583 hasConceptScore W2127848583C2777489490 @default.
• W2127848583 hasConceptScore W2127848583C2777575956 @default.
• W2127848583 hasConceptScore W2127848583C2778690821 @default.
• W2127848583 hasConceptScore W2127848583C2780132546 @default.
• W2127848583 hasConceptScore W2127848583C71924100 @default.
• W2127848583 hasConceptScore W2127848583C76318530 @default.
• W2127848583 hasConceptScore W2127848583C90924648 @default.
• W2127848583 hasIssue "9" @default.
• W2127848583 hasLocation W21278485831 @default.
• W2127848583 hasLocation W21278485832 @default.
• W2127848583 hasOpenAccess W2127848583 @default.
• W2127848583 hasPrimaryLocation W21278485831 @default.
• W2127848583 hasRelatedWork W1555548379 @default.
• W2127848583 hasRelatedWork W1973470095 @default.
• W2127848583 hasRelatedWork W1976481621 @default.
• W2127848583 hasRelatedWork W1979251453 @default.
• W2127848583 hasRelatedWork W1993992685 @default.
• W2127848583 hasRelatedWork W2038285281 @default.
• W2127848583 hasRelatedWork W2141436693 @default.

• next